Open Access

Cholesterol metabolism and the role of PCSK9

Congress Session

About the speaker

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
1 follower

3 more presentations in this session

A global view: the rationale for aggresive LDL lowering

Speaker: Professor S. Nissen (Cleveland, US)

Thumbnail

Show me the data: clinical efficacy, safety and indications of PCSK9 inhibition

Speaker: Professor J. Jukema (Leiden, NL)

Thumbnail

Are there effects of PCSK9 inhibitors beyond cholesterol lowering?

Speaker: Professor B. Cariou (Nantes, FR)

Thumbnail

Access the full session

PCSK9 inhibition - cholesterol reduction and beyond

Speakers: Professor S. Nicholls, Professor S. Nissen, Professor J. Jukema, Professor B. Cariou
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk